As of Nov 17
| +0.01 / +0.02%|
The 9 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 80.00, with a high estimate of 90.00 and a low estimate of 66.00. The median estimate represents a +34.14% increase from the last price of 59.64.
The current consensus among 10 polled investment analysts is to Buy stock in Agios Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.